Tyche Industries, a company in the Pharmaceuticals industry, reported revenue of ₹14 crore and net profit of ₹1.14 crore for the September 2026 quarter.
Tyche Industries (BSE: TYCHE) closed at ₹103.79 on 20 Nov 2026, down 14.2% over the past year. Its market capitalisation is ₹106 crore and it trades at 26.1 times earnings.
Incorporated in 1998, Tyche Industries Ltd does manufacturing of active pharmaceutical ingredients
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.